AlphaYouCJ
Insider selling
Christopher James Stevens sold $128K of Rocket Pharmaceuticals, Inc. (RCKT) stock
Christopher James Stevens, Chief Operating Officer of Rocket Pharmaceuticals, Inc. (RCKT), sold 36,658 shares of RCKT stock worth $128K, per an SEC Form 4 filed Aug 13, 2026.
It was an open-market sale.
The trade happened on Aug 11, 2026, 2 days before it was made public.
RCKT has moved -4.3% since the trade date, from $3.50 to $3.35 (Sep 22, 2026 close).
- Traded
- Aug 11, 2026
- Disclosed
- Aug 13, 2026
- Filing delay
- 2 days
- Price since
- -4.3%
- Role
- Chief Operating Officer
- Source
- SEC Form 4
More RCKT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.